LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. Fundamental Analysis
LeMaitre Vascular, Inc. (LMAT) shows moderate financial fundamentals with a PE ratio of 39.27, profit margin of 22.14%, and ROE of 14.96%. The company generates $0.2B in annual revenue with strong year-over-year growth of 13.63%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 73.1/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze LMAT's fundamental strength across five key dimensions:
Efficiency Score
WeakLMAT struggles to generate sufficient returns from assets.
Valuation Score
WeakLMAT trades at a premium to fair value.
Growth Score
ExcellentLMAT delivers strong and consistent growth momentum.
Financial Health Score
ExcellentLMAT maintains a strong and stable balance sheet.
Profitability Score
ModerateLMAT maintains healthy but balanced margins.
Key Financial Metrics
Is LMAT Expensive or Cheap?
P/E Ratio
LMAT trades at 39.27 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, LMAT's PEG of 3.05 indicates potential overvaluation.
Price to Book
The market values LeMaitre Vascular, Inc. at 5.53 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 22.33 times EBITDA. This signals the market has high growth expectations.
How Well Does LMAT Make Money?
Net Profit Margin
For every $100 in sales, LeMaitre Vascular, Inc. keeps $22.14 as profit after all expenses.
Operating Margin
Core operations generate 25.71 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $14.96 in profit for every $100 of shareholder equity.
ROA
LeMaitre Vascular, Inc. generates $8.92 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
LeMaitre Vascular, Inc. generates strong operating cash flow of $73.36M, reflecting robust business health.
Free Cash Flow
LeMaitre Vascular, Inc. generates strong free cash flow of $66.30M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $2.92 in free cash annually.
FCF Yield
LMAT converts 3.15% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
39.27
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
3.05
vs 25 benchmark
P/B Ratio
Price to book value ratio
5.53
vs 25 benchmark
P/S Ratio
Price to sales ratio
8.70
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.49
vs 25 benchmark
Current Ratio
Current assets to current liabilities
13.58
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.15
vs 25 benchmark
ROA
Return on assets percentage
0.09
vs 25 benchmark
ROCE
Return on capital employed
0.11
vs 25 benchmark
How LMAT Stacks Against Its Sector Peers
| Metric | LMAT Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 39.27 | 29.43 | Worse (Expensive) |
| ROE | 14.96% | 800.00% | Weak |
| Net Margin | 22.14% | -20145.00% (disorted) | Strong |
| Debt/Equity | 0.49 | 0.30 | Weak (High Leverage) |
| Current Ratio | 13.58 | 4.64 | Strong Liquidity |
| ROA | 8.92% | -17936.00% (disorted) | Weak |
LMAT outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews LeMaitre Vascular, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
65.50%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
116.69%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
174.62%
Industry Style: Defensive, Growth, Innovation
High Growth